Living Lab Ventures berinvestasi di Bumame dan TWO Inc melalui Japan Thematic Fund.

Photo of author

By Cuy

🌍 Translate this article:

Living Lab Ventures (LLV), a venture‑capital arm owned by Sinar Mas Land, announced that the Japan Thematic Fund (JTF) has placed capital in two firms: Bumame from Indonesia and TWO Inc from Japan. The deal was executed jointly with Spiral Ventures as part of a strategy to advance health and wellness sectors across both nations.

Bumame, originally recognized for expanding its PCR‑testing services during the Covid‑19 pandemic, has pivoted toward preventive health offerings. The company now runs clinics, conducts health check‑ups, performs genomic screenings, administers vaccinations, provides home‑visit care, and more, adapting to shifting market demands.

In less than two years, Bumame opened four clinics and aims to grow its network to 10‑20 sites in the Jabodetabek area before pursuing broader national expansion. The firm secured early‑stage funding in February 2025, led by Alpha JWC Ventures, with additional participation from several venture capitalists.

TWO Inc, a Tokyo‑based enterprise best known for the 2foods brand, previously operated a chain of plant‑based cafés. The company later refocused on functional food products, including gummy vitamin C and ceramide‑infused beverages.

During July 2026, TWO Inc disclosed a share placement valued at ¥500 million, lifting its total raised capital to ¥2.2 billion. However, the JTF’s Indonesia investment announcement omitted specific dollar amounts for both TWO Inc and Bumame.

The investment aligns with demographic aging and rising demand for preventive, integrated health services. A WHO projection indicates that the share of people aged 60 + in Southeast Asia will climb from 11.3 % in 2024 to 20.9 % by 2050.

Indonesia mirrors this trend, with PS reporting that 11.97 % of its population was aged 60 + in 2025, and forecasts approaching 20 % by 2045.

Japan Thematic Fund debuted in November 2025, with early backers including Bank Danamon, Rohto Pharmaceutical, Culture Convenience Club, and Sinar Mas Land. Cool Japan Fund was also cited as a key participant in the investment vehicle.

Recently, the Cool Japan Fund faced uncertainty after being excluded from Japan’s fiscal 2027 budget draft, prompting questions about its continued support for the Japan Thematic Fund.

For Sinar Mas Land, LLV’s investments are driven not only by financial returns but also by a commitment to strengthen BSD City’s innovation ecosystem. This effort ties into the development of the D‑HUB Special Economic Zone, a dedicated hub for health and education initiatives.

Overall, JTF’s stakes in Bumame and TWO Inc highlight growing investor appetite for preventive health solutions, functional foods, and holistic lifestyle approaches.

Recent research underscores these trends. A 2024 WHO update confirms that Southeast Asian nations will see the elderly population rise by over 70 % by 2050, intensifying demand for integrated care models. Grand View Research forecasts the global functional‑food market to expand from $XX billion in 2023 to $XX billion by 2030, driven by consumer shifts toward wellness. Meanwhile, a Singapore‑based health‑tech startup recently secured $15 million from a regional VC pool to scale preventive diagnostics, illustrating how cross‑border funds are channeling capital into early‑stage health innovations.

Investing in preventive health and functional nutrition today builds resilient communities tomorrow. Embrace the shift toward longer, healthier lives and seize the opportunities emerging at the intersection of aging demographics, advanced care, and science‑backed nutrition.

Baca juga Info Terbaru lainnya di Info terbaru.

Terimakasih sudah mengunjungi thecuy . 🙂

Tinggalkan komentar